Dana Albright
Overview
Explore the profile of Dana Albright including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watanabe M, Reynolds E, Banerjee M, Charles M, Mizokami-Stout K, Albright D, et al.
Diabetes Care
. 2024 Jul;
47(9):1638-1646.
PMID: 39008530
Objective: To determine bidirectional associations between the timing of chronic diabetes complications (CDCs) and mental health disorders (MHDs) in individuals with type 1 or type 2 diabetes. Research Design And...
2.
Albright D, Wardell J, Harrison A, Mizokami-Stout K, Hirschfeld E, Garrity A, et al.
J Pediatr Psychol
. 2024 Apr;
49(5):356-364.
PMID: 38647266
Objective: The purpose of this study is to examine diabetes distress as a potential mediator of the relationship between depression symptoms and diabetes outcomes, including hemoglobin A1c (hemoglobin A1c [HbA1c])...
3.
Wardell J, Albright D, Chang C, Plegue M, Lee J, Hirschfeld E, et al.
Sci Diabetes Self Manag Care
. 2024 Mar;
50(2):116-129.
PMID: 38456252
Purpose: The purpose of this study was to describe the frequency of psychosocial risk and its associations with glycemic levels in youth with type 1 diabetes (T1D) seen by social...
4.
Reynolds E, Mizokami-Stout K, Putnam N, Banerjee M, Albright D, Ang L, et al.
Diabetes Res Clin Pract
. 2023 Oct;
205:110983.
PMID: 37890702
Aims: Describe and compare healthcare costs and utilization for insured persons with type 1 diabetes (T1D), type 2 diabetes (T2D), and without diabetes in the United States. Methods: Using a...
5.
Miller A, Albright D, Bauer K, Riley H, Hilliard M, Sturza J, et al.
J Pediatr Psychol
. 2022 May;
47(8):873-882.
PMID: 35609567
Objective: The COVID-19 pandemic increased economic, social, and health stressors for families, yet its impacts on families of youth with chronic conditions, such as type 1 diabetes (T1D), are not...
6.
Putnam N, Reynolds E, Banerjee M, Mizokami-Stout K, Albright D, Lee J, et al.
Front Endocrinol (Lausanne)
. 2022 Mar;
13:834978.
PMID: 35317223
Objective: To determine the prevalence of neuropsychological outcomes in individuals with type 1 diabetes compared to individuals with type 2 diabetes or without diabetes, and to evaluate the association of...
7.
Bauer K, Hilliard M, Albright D, Lo S, Fredericks E, Miller A
Curr Diab Rep
. 2020 Jul;
20(8):37.
PMID: 32638126
Purpose Of Review: Youth with strong self-regulation (SR), or the ability to manage thoughts, emotions, and behaviors, engage in more effective type 1 diabetes (T1D) management. However, while parent support...
8.
Miller A, Lo S, Albright D, Lee J, Hunter C, Bauer K, et al.
BMC Pediatr
. 2020 Mar;
20(1):112.
PMID: 32145739
Background: Self-regulation (SR), or the capacity to control one's thoughts, emotions, and behaviors in order to achieve a desired goal, shapes health outcomes through many pathways, including supporting adherence to...
9.
Syzmanski T, Casey R, Johnson A, Cano A, Albright D, Seivert N
Front Vet Sci
. 2019 Jan;
5:302.
PMID: 30619894
There is limited research assessing the effectiveness of Animal-Assisted Therapy in at-risk adolescent populations. In a recent study, 138 adjudicated adolescents participated in a randomized controlled trial of an animal-assisted...